Study: NCT05804123

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Augmentin 500Mg Tablet
Description: Augmentin (GlaxoSmithKline Pte, product declaration No. VN-20169-16) is an oral antibiotic available in the form of 625 mg tablets, which are prescribed as routine treatment for children and adults, respectively.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Augmentin 500Mg Tablet
Description: Augmentin (GlaxoSmithKline Pte, product declaration No. VN-20169-16) is an oral antibiotic available in the form of 625 mg tablets, which are prescribed as routine treatment for children and adults, respectively.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Acetylcysteine
Description: Acetylcysteine 200 mg (STADA Vietnam, product declaration No. VD-22667-15) is an oral expectorant, which is prescribed as routine treatment for children and adults, respectively.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetylcysteine
Description: Acetylcysteine 200 mg (STADA Vietnam, product declaration No. VD-22667-15) is an oral expectorant, which is prescribed as routine treatment for children and adults, respectively.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Xylometazoline Nasal
Description: Otrivin (Xylometazoline 0.05%) (Novartis VietNam, product declaration No. VN-15558-12) is a nasal-spraying decongestant, which is prescribed as routine treatment for children and adults, respectively.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Xylometazoline Nasal
Description: Otrivin (Xylometazoline 0.05%) (Novartis VietNam, product declaration No. VN-15558-12) is a nasal-spraying decongestant, which is prescribed as routine treatment for children and adults, respectively.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Xylometazoline Nasal
Description: Otrivin (Xylometazoline 0.05%) (Novartis VietNam, product declaration No. VN-15558-12) is a nasal-spraying decongestant, which is prescribed as routine treatment for children and adults, respectively.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Xylometazoline Nasal
Description: Otrivin (Xylometazoline 0.05%) (Novartis VietNam, product declaration No. VN-15558-12) is a nasal-spraying decongestant, which is prescribed as routine treatment for children and adults, respectively.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Cefotaxime
Description: Imetoxim 1g (Cefotaxime 1g) (Imexpharm Pharmaceutical, product declaration No. VD-26846-17) is an injection or infusion-administrative antibiotic, which is prescribed as routine treatment for children.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cefotaxime
Description: Imetoxim 1g (Cefotaxime 1g) (Imexpharm Pharmaceutical, product declaration No. VD-26846-17) is an injection or infusion-administrative antibiotic, which is prescribed as routine treatment for children.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ciprofloxacin
Description: Ciprofloxacin 0.3% (Vidipha Central Pharmaceutical, product declaration No. VD-15205-11) is an antibiotic ear drop, which is prescribed as routine treatment for children.